FOLH1 and prostate cancer: Quantitative PSMA PET Biomarkers for Predicting Response to &lt;sup&gt;177&lt;/sup&gt;Lu-PSMA Therapy in Prostate Cancer: A Systematic Review and Meta-analysis.